Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (221-230 of 292) with videos related to

Pageof 30
Sort By:
Scientific Reports|June 22, 2016
The embryological basis of subclinical hypertrophic cardiomyopathyGabriella Captur, Carolyn Y Ho, Saskia Schlossarek, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2024
Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized PacingJames W Malcolmson, Rebecca K Hughes, Tim Husselbury, et al.
Heart (British Cardiac Society)|September 1, 2012
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and diseaseDaniel M Sado, Andrew S Flett, Sanjay M Banypersad, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 6, 2014
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonanceSilvia Pica, Daniel M Sado, Viviana Maestrini, et al.
Ebiomedicine|April 8, 2020
Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage diseaseDan Hu, Dong Hu, Liwen Liu, et al.
Journal of the American College of Cardiology|August 7, 2010
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathyRory O'Hanlon, Agata Grasso, Michael Roughton, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
Kardiologia Polska|December 20, 2014
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy], Perry M Elliott, Aris Anastasakis, et al.
JACC. Cardiovascular Imaging|June 6, 2020
DPD Quantification in Cardiac Amyloidosis: A Novel Imaging BiomarkerPaul R Scully, Elizabeth Morris, Kush P Patel, et al.
European Heart Journal|September 1, 2014
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Perry M Elliott, Aris Anastasakis, et al.
Pageof 30

Showing results (221-230 of 292) with videos related to

Sort By:
Pageof 30
Scientific Reports|June 22, 2016
The embryological basis of subclinical hypertrophic cardiomyopathyGabriella Captur, Carolyn Y Ho, Saskia Schlossarek, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2024
Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized PacingJames W Malcolmson, Rebecca K Hughes, Tim Husselbury, et al.
Heart (British Cardiac Society)|September 1, 2012
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and diseaseDaniel M Sado, Andrew S Flett, Sanjay M Banypersad, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 6, 2014
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonanceSilvia Pica, Daniel M Sado, Viviana Maestrini, et al.
Ebiomedicine|April 8, 2020
Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage diseaseDan Hu, Dong Hu, Liwen Liu, et al.
Journal of the American College of Cardiology|August 7, 2010
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathyRory O'Hanlon, Agata Grasso, Michael Roughton, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
Kardiologia Polska|December 20, 2014
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy], Perry M Elliott, Aris Anastasakis, et al.
JACC. Cardiovascular Imaging|June 6, 2020
DPD Quantification in Cardiac Amyloidosis: A Novel Imaging BiomarkerPaul R Scully, Elizabeth Morris, Kush P Patel, et al.
European Heart Journal|September 1, 2014
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Perry M Elliott, Aris Anastasakis, et al.
Pageof 30